HCC risk remains after DAA-cured HCV in individuals with HIV, but the annual probability of developing HCC declines over 6 years.

Ablation therapy demonstrated comparable effectiveness for HCC in patients with hepatitis B-related recompensated vs compensated cirrhosis.

The 2024 to 2025 COVID-19 vaccine reduced the risk for ED visits, hospitalizations, and deaths among US veterans.

Bivalent RSV pre-F vaccine exhibited high effectiveness against RSV-associated hospitalization in older adults aged 75 to 79 years in England.

Racial and ethnic disparities in pediatric COVID-19 severity were largest among hospitalized Black and Hispanic children with CCCs or government insurance.

In adults aged 18 to 64 years at increased risk for pneumococcal disease due to chronic conditions, the 21-valent pneumococcal conjugate vaccine (V116) is highly immunogenic and well-tolerated, ...

A COVID-19 diagnosis was associated with a higher risk for arterial thromboembolism, venous thromboembolism, thrombocytopenia, myocarditis or pericarditis, and inflammatory conditions in the first ...